Summary
Molecular recognition is mediated by three main factors: surface complementarity, thermodynamics, and associated physicochemical properties. These principles are responsible for ligand–target binding and therefore serve as the foundation for the design of new biologically relevant chemical entities. As these principles are involved in nearly all biological processes, a firm understanding of the details involved in binding is necessary for drug design. The consideration of these factors individually has proven useful; however, the combined effect of these governing principles is most important. And despite extensive studies, there are still many gaps in our understanding of this recognition process. The aim of this chapter is to introduce the basic concepts of ligand binding to set the stage for the following chapters, while briefly discussing fundamental techniques of drug design, including the indispensable tools of molecular modeling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fischer, E. (1894). Einfluss der Configuration auf die Wirkung der Enzyme. Ber. Dtsch. Chem. Ges. 27, 2985–2993
Koshland, D. (1958). Application of a theory of enzyme specificity to protein synthesis. Proc. Natl. Acad. Sci. U.S.A. 44, 98
Gellman, S. H. (1997). Introduction: molecular recognition. Chem Rev 97, 1231–1232
Lehn, J. M. (1993). Supramolecular chemistry. Science 260, 1762–1763
Schneider, H. J. and Yatsimirski, A. (2002). Principles and methods in supramolecular chemistry. Chichester: Wiley
Steed, J. W. and Atwood, J. L. (2000). Supra-molecular chemistry. Chichester: Wiley
Oshovsky, G. V., Reinhoudt, D. N. and Verboom, W. (2007). Supramolecular chemistry in water. Angew. Chem. Int. Ed. Engl. 46, 2366–2393
Retrieved from http://nobelprize.org/nobel_prizes/chemistry/laureates/1987/
Chervenak, M. C. and Toone, E. J. (1994). A direct measure of the contribution of solvent reorganization to the enthalpy of ligand binding. J. Am. Chem. Soc. 116, 10533–10539
Fisher, H. F. and Singh, N. (1995). Calorimetric methods for interpreting protein-ligand interactions. Methods Enzymol 259, 194–221
Murphy, K. P., Xie, D., Thompson, K. S., Amzel, L. M., et al. (1994). Entropy in biological binding processes: estimation of translational entropy loss. Proteins 15, 113–120
Gilli, P., Ferretti, V., Gilli, G., and Borea, P. A. (1994). Enthalpy-entropy compensation in drug receptor binding. J. Phys. Chem. 98, 1515–1518
Brady, P. B. and Sharp, K. A. (1997). Entropy in protein folding and in protein-protein interactions. Curr. Opin. Struct. Biol. 7, 215–221
Page, M. I. and Jencks, W. P. (1971). Entropic contributions to rate acceleration in enzymic and intramolecular reactions and the chelate effect. Proc. Natl. Acad. Sci. U.S.A. 68, 1678–1683
Searle, M. S. and Williams, D. H. (1992). The cost of conformational order: entropy changes in molecular associations. J. Am. Chem. Soc. 114, 10690–10697
Jeffrey, G. A. and Saenger, W. (1991). Hydrogen bonding in biological structures. Berlin: Springer
Frank, H. S. and Evans, M. W. (1945). Free volume and entropy in condensed systems III. J. Chem. Phys. 13, 507
Nicholls, A., Mobley, D. L., Guthrie, J. P., Chodera, J. D., et al. (2008). Predicting small-molecule solvation free energies: an informal blind test fro computational chemistry. J. Med. Chem. 1, 769–779
Poornima, C. S. and Dean, P. M. (1995). Conserved water molecules at the ligand-binding sites of homologous proteins. J. Comput. Aided Mol. Des. 9, 500–512
Amadasi, A., Surface, J. A., Spyrakis, F., Cozzini, P., et al. (2008). Robust classification of “relevant” water molecules in putative protein binding sites. J. Med. Chem. 51, 1063–1067
Pauling, L. (1939). The nature of the chemical bond and the structure of molecules and crystals. Ithaca, NY: Cornell University Press
Platts, J. A., Howard, S. T. and Bracke, B. R. (1996). Directionality of hydrogen bonds to sulfur and oxygen. J. Am. Chem. Soc. 118, 2726–2733
Warshel, A., Papazyan, A., Kollman, P. A., Cleland, W. W., et al. (1995). On low-barrier hydrogen bonds and enzyme catalysis. Science 269, 102–106
Taylor, R. and Kennard, O. (1984). Hydrogen-bond geometry in organic crystals. Acc. Chem. Res. 17, 320–326
Mcdonald, I. K. and Thornton, J. M. (1994). Satisfying hydrogen bonding potentials in proteins. J. Mol. Biol. 238, 777–793
Vega, S., Kang, L.-W., Velazquez-Campoy, A., Kiso, Y., et al. (2004). A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease. Proteins 55, 594–602
Nishio, M. and Hirota, M. (1989). CH/π interaction: implication in organic chemistry. Tetrahedron 45, 7201–7245
Sussman, J. L., Harel, M., Frolow, F., Oefner, C., et al. (1991). Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253, 872–879
Dougherty, D. A. (1996). Cation/π interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 271, 163–168
Gallivan, J. P. and Dougherty, D. A. (1999). Cation/π interactions in structural biology. Proc. Natl. Acad. Sci. U.S.A. 96, 9459–9464
Ma, J. C. and Dougherty, D. A. (1997). The cation/π interaction. Chem. Rev. 97, 1303–1324
Blokzijl, W. and Engberts, J. (1993). Hydrophobic effects. Opinion and facts. Angew. Chem. Int. Ed. Engl. 32, 1545–1579
Urzhumtsev, A., Tete-Favier, F., Mitschler, A., Barbanton, J., et al. (1997). A ‘specificity’ pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure 5, 601–612
Mccurdy, C. R., Le Bourdonnec, B., Metzger, T. G., El Kouhen, R., et al. (2002). Naphthalene dicarboxaldehyde as an electrophilic fluorogenic moiety for affinity labeling: application to opioid receptor affinity labels with greatly improved fluorogenic properties. J. Med. Chem. 45, 2887–2890
White, R. J., Margolis, P. S., Trias, J. and Yuan, Z. (2003). Targeting metalloenzymes: a strategy that works. Curr. Opin. Pharmacol. 3, 502–507
Pearson, R. G. (1963). Hard and soft acids and bases. J. Am. Chem. Soc. 85, 3533–3539
Sabat, M. (1990). Ternary metal ion-nucleic acid base protein complexes. In: Sigel, H. and Sigel, A. (Eds.), Metal ions in biological systems. New York: Marcel Dekker, pp. 521
Friedman, H. L. (1951). Influence of isosteric replacements upon biological activity. N ASNRS 206, 295−358
Burger, A. (1991). Isosterism and bioisosterism in drug design. Prog. Drug. Res. 37, 287–371
Langmuir, I. (1919). Isomorphism, isosterism, and covalence. J. Am. Chem. Soc. 41, 1543–1559
Patani, G. A. and LaVoie, E. J. (1996). Bioisosterism: a rational approach in drug design. Chem. Rev. 96, 3147–3176
Mohan, V., Gibbs, A. C., Cummings, M. D., Jaeger, E. P., et al. (2005). Docking: Succe-sses and challenges. Curr. Pharm. Des. 11, 323–333
Erickson, J. A., Jalaie, M., Robertson, D. H., Lewis, R. A., et al. (2004). Lessons in molecular recognition: The effects of ligand and protein flexibility on molecular docking accuracy. J. Med. Chem. 47, 45–55
Xu, H. and Agrafiotis, D. K. (2002). Retrospect and prospect of virtual screening in drug discovery. Curr. Top. Med. Chem. 2, 1305–1320
Patny, A., Desai, P. V. and Avery, M. A. (2006). Homology modeling of G-protein-coupled receptors and implications in drug design. Curr. Med. Chem. 13, 1667–1691
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., et al. (2000). Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739–745
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G., et al. (2007). High-resolution crystal structure of an engineered human B2 adrenergic G protein-coupled receptor. Science 318, 1258–1265
Rasmussen, S. G., Choi, H.-J., Rosenbaum, D. M., Kobilka, T. S., et al. (2007). Crystal structure of the human B2 adrenergic G protein-coupled receptor. Nature 450, 383–387
Kubinyi, H. (2002). From narcosis to hyperspace: the history of QSAR. Quant. Struct.-Act. Relat. 21, 348–356
Hansch, C. and Fujita, T. (1964). A method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc. 86, 1616–1626
Kubinyi, H. (1997). QSAR and 3D QSAR in drug design. Part 1: methodology. Drug Discov. Today 2, 457–467
Kubinyi, H. (1997). QSAR and 3D QSAR in drug design. Part 2: applications and problems. Drug Discov. Today 2, 538–546
Good, A. C., Mason, J. S. and Pickett, S. D. (2000). Pharmacophore pattern application in virtual screening, library design, and QSAR. In: Bohm, H.-J. and Schneider, G. (Eds.), Virtual screening for bioactive molecules. Weinheim: Wiley-VCH
Kurogi, Y. and Guner, O. F. (2001). Pharmacophore modeling and three-dimensional database searching for drug design using Catalyst. Curr. Med. Chem. 8, 1035–1055
Portoghese, P. S. (1992). The role of concepts in structure-activity relationship studies of opioid ligands. J. Med. Chem. 35, 1927–1937
Tamiz, A. P., Zhang, J., Zhang, M., Wang, C. Z., et al. (2000). Application of the bivalent ligand approach to the design of novel dimeric serotonin reuptake inhibitors. J. Am. Chem. Soc. 122, 5393
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press
About this protocol
Cite this protocol
Nolan, T., Singh, N., McCurdy, C.R. (2010). Ligand Macromolecule Interactions: Theoretical Principles of Molecular Recognition. In: Roque, A. (eds) Ligand-Macromolecular Interactions in Drug Discovery. Methods in Molecular Biology, vol 572. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-244-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-60761-244-5_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-243-8
Online ISBN: 978-1-60761-244-5
eBook Packages: Springer Protocols